What Is KCS in Dogs? Symptoms, Causes & Treatment

Keratoconjunctivitis sicca, commonly called KCS or “dry eye,” is a condition in which a dog’s eyes fail to produce enough tears to keep the corneal surface healthy and comfortable. The tear film does more than keep the eye moist; it delivers oxygen, washes away debris, and fights off bacteria. When that film breaks down, the result is chronic irritation, a gummy discharge, and progressive damage to the cornea that can eventually threaten vision. KCS is one of the most frequently diagnosed eye conditions in dogs, and while it usually requires lifelong management, most dogs do well once treatment is dialed in.

What the Tear Film Actually Does

A dog’s tear film is not simply saltwater sitting on the eye. It has a layered structure with distinct jobs: a thin outer lipid layer that slows evaporation, a watery middle layer packed with antimicrobial proteins and nutrients, and an inner mucin layer that helps the tears stick evenly across the cornea.¹ When any part of that system underperforms, the surface of the eye dries out in patches, loses its natural defenses, and becomes vulnerable to infection and ulceration. In most KCS cases, the problem is a shortage of the aqueous (watery) component, which is produced mainly by the lacrimal gland and the gland of the third eyelid.²

How to Recognize KCS

The signs of dry eye tend to build gradually, so many owners assume at first that their dog just has a minor eye infection. The most obvious early clue is a thick, yellowish-green discharge clinging to the eye and the fur around it. Because there is not enough liquid tear to flush the surface, mucus and cellular debris accumulate into that sticky mess. You may notice your dog squinting, pawing at the face, or blinking more than usual. The whites of the eyes often look red and inflamed, and the conjunctiva (the tissue lining the inner eyelids) becomes puffy.

As the condition progresses without treatment, the cornea itself starts to change. A brown or dark pigment gradually creeps across the surface, a process called pigmentary keratitis. Blood vessels may grow into the cornea, and the once-clear tissue can develop a dull, hazy appearance. In advanced cases, corneal ulcers can form because the eye lacks the protective tear barrier. These ulcers are painful and, if deep enough, can lead to perforation of the eye. This is why catching KCS early matters so much: the corneal changes are often irreversible once they set in, but treatment can halt or slow them dramatically.

What Causes Dry Eye in Dogs

The single most common cause is the dog’s own immune system attacking the tear-producing glands. This immune-mediated destruction accounts for the majority of KCS cases and looks a lot like what happens in human Sjögren syndrome, where the body’s defenses mistakenly target moisture-producing glands.³ Nobody knows exactly what triggers the immune response in every case, but genetics clearly plays a role. Certain breeds show up in veterinary ophthalmology clinics far more often than others. English Bulldogs, Cocker Spaniels, West Highland White Terriers, Pugs, Shih Tzus, Lhasa Apsos, and Yorkshire Terriers are among the most commonly affected.

Beyond the immune-mediated form, several other causes exist:

• Drug-induced: Certain medications can damage the lacrimal gland. Sulfonamide antibiotics used long-term, for instance, have been linked to KCS as a toxic side effect on the gland.⁴ Some anti-inflammatory drugs and certain anesthetics can temporarily reduce tear production as well.
• Congenital: Cavalier King Charles Spaniels can be born with a form of KCS linked to an inherited skin condition called ichthyosiform dermatosis. Pedigree analysis suggests this is passed along in an autosomal recessive pattern, meaning a puppy needs a copy of the gene from each parent to be affected.⁵
• Neurogenic: Damage to the facial nerve or the nerves that control tear secretion can shut down production on the affected side. Dogs with facial nerve dysfunction are prone to developing neurogenic KCS, and these cases can be especially stubborn to manage.⁶
• Other triggers: Hypothyroidism, canine distemper, diabetes, and removal of the third eyelid gland (sometimes done during cherry eye surgery) can all contribute to reduced tear output. Radiation therapy near the head is another uncommon cause.

In many dogs, the underlying trigger is never identified with certainty. Even when the immune-mediated form is suspected, it is often a clinical diagnosis based on breed, presentation, and response to treatment rather than confirmed by biopsy.

How Veterinarians Diagnose KCS

The workhorse diagnostic tool is the Schirmer tear test. Your vet places a small strip of absorbent paper inside the lower eyelid for one minute and measures how far the moisture wicks along the strip. In healthy dogs, values typically land around 20 to 23 mm per minute.⁷ Dogs with KCS often measure well below 10 mm per minute, and severe cases may be at or near zero.⁸ Readings between 10 and 15 mm per minute fall into a gray zone where early or mild KCS is possible but not certain; your vet may re-test on a different day or look at additional clues.

Beyond the Schirmer test, vets use fluorescein stain to check for corneal ulcers or erosions invisible to the naked eye. A tear film breakup time test can reveal how quickly the tear layer falls apart between blinks. In healthy dogs that breakup time averages around 20 to 26 seconds; in KCS dogs it can drop to roughly 10 seconds or less.⁸ A thorough eye exam also looks at corneal clarity, pigmentation, blood vessel growth, and the degree of conjunctival redness, all of which help gauge how advanced the disease is and how urgently treatment is needed.

Medical Treatment

The primary treatment for immune-mediated KCS is an immunosuppressive eye drop that calms the gland-destroying immune response while simultaneously coaxing the remaining lacrimal tissue to produce more tears. Cyclosporine, applied topically once or twice a day, has been the go-to drug for decades. Tacrolimus, a related but more potent immunosuppressant, is the usual second-line option when cyclosporine alone does not produce enough improvement. Both drugs work by the same general principle, and studies comparing the two have found they produce similar increases in tear output over several months of use.⁹

The improvements are not instant. It can take four to eight weeks, sometimes longer, before tear production measurably increases. During that ramp-up period, and often indefinitely, artificial tear supplements are used to keep the eye lubricated and comfortable. Hyaluronic acid-based drops have shown some advantages here: in one study of 25 dogs, switching from a standard carbomer gel to a hyaluronate-based drop twice daily reduced conjunctival redness and discomfort scores more effectively.¹⁰ If a secondary bacterial infection is present, your vet may add a short course of antibiotic eye drops.

A newer formulation combines tacrolimus with cross-linked hyaluronate in a single drop. This combination improved tear film stability in dogs with evaporative dry eye, roughly doubling their tear breakup time over 45 days.¹¹ Hyaluronate used on its own also helped, but the effect was less pronounced even when given more frequently.¹² The trend in veterinary ophthalmology is clearly moving toward combination products that tackle multiple components of the tear film at once.

When Drops Are Not Enough

Some dogs simply do not respond to medical therapy. Their lacrimal glands may be too severely damaged by the time KCS is diagnosed, or the underlying cause may not be immune-mediated at all, making immunosuppressive drops ineffective. For these cases, a surgery called parotid duct transposition can be a viable rescue. The procedure reroutes one of the salivary ducts so that saliva, rather than tears, bathes the eye. Saliva is not a perfect stand-in for tears, but it does keep the corneal surface wet.

In a retrospective review of 92 eyes that underwent parotid duct transposition, the surgical success rate was about 92%.¹³ That sounds encouraging, but the complication rate tells a more nuanced story: half the eyes developed some kind of complication. Most were manageable with medication, but roughly a third of those complications required additional surgery. The main issues include mineral deposits (sialoliths) forming inside the rerouted duct, excessive saliva causing irritation, and occasionally the duct failing or becoming blocked.¹⁴ Dogs that have had the surgery also tend to “tear up” when they eat, since the salivary gland naturally activates during meals. Despite these quirks, for a dog that would otherwise face constant corneal ulceration and pain, it can be a worthwhile trade-off.

Stem Cell Therapy and Other Emerging Approaches

Research into regenerative treatments has generated some excitement. The basic idea is that mesenchymal stem cells, which can be harvested from donor fat tissue or bone marrow, could be injected into the damaged lacrimal gland to calm the immune attack and possibly regenerate functional tissue. In one study, a single injection of about one million stem cells directly into the lacrimal glands of 24 KCS-affected eyes produced a significant increase in tear production. In dogs with mild to moderate disease, tear test values returned to healthy levels. Dogs with severe KCS also improved, though not as dramatically. The effect lasted up to 12 months after just one treatment, a stark contrast to the daily drops required by conventional therapy.¹⁵

A separate study tried a topical approach, applying stem cells to the eye surface rather than injecting them. Over half of the dogs treated this way saw meaningful improvement in tear volume, and that included dogs that had previously failed to respond to standard immunosuppressive drops.¹⁶ These are small studies with limited follow-up, and stem cell therapy for KCS is not yet widely available or standardized. A systematic review and meta-analysis of the existing data has been published, reflecting growing interest in pulling the evidence together.¹⁷ Still, the prospect of a single treatment replacing years of twice-daily drops is compelling enough that more trials are almost certainly on the way.

Living with a KCS Dog

For most owners, managing KCS settles into a routine that becomes second nature. Twice-daily eye drops are the norm. Some dogs need an artificial tear supplement in addition to their cyclosporine or tacrolimus, which can mean three or four applications a day at first. Keeping the area around the eyes clean is important; gently wiping away accumulated discharge with a warm, damp cloth helps prevent matting and secondary skin irritation. Most dogs tolerate the drops well once they get used to the process, and positive reinforcement with treats goes a long way.

Regular rechecks matter because KCS can quietly worsen even when the eye looks acceptable to a non-professional. Your vet will re-run the Schirmer test periodically to verify that tear production is staying in a safe range and check for early corneal changes you might not spot at home. If you notice your dog suddenly squinting more, pawing at the eye, or if the discharge changes character or increases sharply, those are signs of a possible ulcer or flare-up that warrants a prompt visit rather than waiting for the next scheduled appointment.

One common source of frustration is the cost and logistics of compounded medications. Cyclosporine is available in a commercially manufactured ophthalmic ointment, but tacrolimus is almost always a compounded preparation, and its shelf life is limited. Owners in rural areas sometimes have trouble finding a reliable compounding pharmacy. Storing the medications properly (usually refrigerated for compounded tacrolimus) and reordering before you run out is one of those unglamorous but critical parts of long-term management.

Breeds That Need Extra Vigilance

Breed predisposition to KCS is well documented, though having a predisposed breed does not mean your dog will inevitably develop the condition. Brachycephalic breeds (those with flat faces and prominent eyes) are disproportionately represented. Part of the reason may be anatomical: their wide eye openings and shallow orbits increase tear evaporation and expose more corneal surface. But genetics also independently increase the risk of the immune-mediated gland destruction itself in many of these breeds.

If you own one of the high-risk breeds, asking your vet to include a Schirmer test as part of the annual exam is reasonable. Catching a downward trend in tear production before clinical signs appear gives you a head start on treatment and a much better chance of preserving corneal health long-term. This is especially true for Cavalier King Charles Spaniels, where the congenital form can appear very early in life and be accompanied by skin abnormalities that signal the underlying genetic condition.⁵

Why Dry Eye Sometimes Gets Missed

Despite being common, KCS is underdiagnosed, particularly in its early stages. The thick discharge looks enough like a bacterial eye infection that some dogs go through round after round of antibiotics without improvement before anyone thinks to run a tear test. Antibiotic drops may temporarily reduce the discharge by knocking back secondary bacteria, which reinforces the misdiagnosis and delays the real fix. If your dog has recurring “eye infections” that keep coming back after treatment, KCS should be on the list of suspects.

Another diagnostic pitfall involves neurogenic KCS. When only one eye is affected and the dog also has a droopy ear or lip on the same side, the underlying problem is often nerve damage rather than an immune attack on the gland. These cases do not respond to cyclosporine or tacrolimus in the usual way because the gland itself is intact but simply not receiving the nerve signal to produce tears.⁶ Some neurogenic cases can be stimulated with a drug called pilocarpine, given orally or topically, which bypasses the damaged nerve pathway. Identifying the neurogenic form matters because the treatment and prognosis differ from the immune-mediated version.

Drug-induced KCS is another form worth knowing about because it is potentially reversible. If tear production drops during or shortly after a course of certain medications, particularly sulfonamide antibiotics, stopping the offending drug may allow the gland to recover. The longer the toxic exposure continues, though, the less likely full recovery becomes.⁴ This is one of the reasons veterinarians monitor for eye changes when prescribing drugs known to carry this risk.